Cite
EXHANCE‐12: 1‐year study of the exhalation delivery system with fluticasone (EDS‐FLU) in chronic rhinosinusitis.
MLA
Palmer, James N., et al. “EXHANCE‐12: 1‐year Study of the Exhalation Delivery System with Fluticasone (EDS‐FLU) in Chronic Rhinosinusitis.” International Forum of Allergy & Rhinology, vol. 8, no. 8, Aug. 2018, pp. 869–76. EBSCOhost, https://doi.org/10.1002/alr.22141.
APA
Palmer, J. N., Jacobson, K. W., Messina, J. C., Kosik, G. C., Djupesland, P. G., & Mahmoud, R. A. (2018). EXHANCE‐12: 1‐year study of the exhalation delivery system with fluticasone (EDS‐FLU) in chronic rhinosinusitis. International Forum of Allergy & Rhinology, 8(8), 869–876. https://doi.org/10.1002/alr.22141
Chicago
Palmer, James N., Kraig W. Jacobson, John C. Messina, Gonzalez, Colette Kosik, Per G. Djupesland, and Ramy A. Mahmoud. 2018. “EXHANCE‐12: 1‐year Study of the Exhalation Delivery System with Fluticasone (EDS‐FLU) in Chronic Rhinosinusitis.” International Forum of Allergy & Rhinology 8 (8): 869–76. doi:10.1002/alr.22141.